Evidence map›Paper›PMID 33459422›Full record

ArticleThe EMBO journal2021

Transcriptional repression of NFKBIA triggers constitutive IKK- and proteasome-independent p65/RelA activation in senescence.

Marina Kolesnichenko, Nadine Mikuda, Uta E Höpken, Eva Kärgel, Bora Uyar, Ahmet Bugra Tufan, Maja Milanovic, Wei Sun, Inge Krahn, Kolja Schleich and 9 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Marina KolesnichenkoSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0001-7366-9061
Nadine MikudaSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Uta E HöpkenMicroenvironmental Regulation in Autoimmunity and Cancer, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Eva KärgelSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Bora UyarBioinformatics/Mathematical Modeling Platform, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-3170-4890
Ahmet Bugra TufanSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Maja MilanovicDepartment of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin, Berlin, Germany.ORCID 0000-0003-1860-6003
Wei SunLaboratory for Functional Genomics and Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0001-9607-1361
Inge KrahnSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Kolja SchleichDepartment of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin, Berlin, Germany.
Linda von HoffSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Michael HinzSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Michael WillenbrockSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Sabine JungmannSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Altuna AkalinBioinformatics/Mathematical Modeling Platform, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-0468-0117
Soyoung LeeDepartment of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin, Berlin, Germany.
Ruth Schmidt-UllrichSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-2472-6530
Clemens A SchmittDepartment of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin, Berlin, Germany.
Claus ScheidereitSignal Transduction in Tumor Cells, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-0446-6129
Max Delbrück Center · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The IκB kinase (IKK)-NF-κB pathway is activated as part of the DNA damage response and controls both inflammation and resistance to apoptosis. How these distinct functions are achieved remained unknown. We demonstrate here that DNA double-strand breaks elicit two subsequent phases of NF-κB activation in vivo and in vitro, which are mechanistically and functionally distinct. RNA-sequencing reveals that the first-phase controls anti-apoptotic gene expression, while the second drives expression of senescence-associated secretory phenotype (SASP) genes. The rapidly activated first phase is driven by the ATM-PARP1-TRAF6-IKK cascade, which triggers proteasomal destruction of inhibitory IκBα, and is terminated through IκBα re-expression from the NFKBIA gene. The second phase, which is activated days later in senescent cells, is on the other hand independent of IKK and the proteasome. An altered phosphorylation status of NF-κB family member p65/RelA, in part mediated by GSK3β, results in transcriptional silencing of NFKBIA and IKK-independent, constitutive activation of NF-κB in senescence. Collectively, our study reveals a novel physiological mechanism of NF-κB activation with important implications for genotoxic cancer treatment.

Indexed as

AnimalsApoptosisCell LineCell ProliferationCellular SenescenceDNA Breaks, Double-StrandedDNA RepairFemaleGene SilencingGlycogen Synthase Kinase 3 betaHEK293 CellsHumansI-kappa B KinaseMiceMice, Inbred C57BLNF-KappaB Inhibitor alphaGlycogen Synthase Kinase 3 betaGSK3B protein, humanI-kappa B KinaseNF-KappaB Inhibitor alphaNFKBIA protein, humanProteasome Endopeptidase ComplexRELA protein, humanTranscription Factor RelADNA damage responseIκBαNF-κBSASPsenescence

Identifiers

PMID33459422
PMCPMC7957429
OpenAlexW3124043633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.